These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 23123689)

  • 1. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
    Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
    Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
    J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorders in Parkinson's disease in a Chinese population.
    Fan W; Ding H; Ma J; Chan P
    Neurosci Lett; 2009 Nov; 465(1):6-9. PubMed ID: 19560522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
    Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the development of impulse compulsive disorders in Parkinson patients.
    Rana AQ; Mansoor W; Hussaini S; Al Mosabbir A; Rahman M; Rahman L
    Int J Neurosci; 2013 Jul; 123(7):503-6. PubMed ID: 23336737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorders in Parkinson's disease.
    Vilas D; Pont-Sunyer C; Tolosa E
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S80-4. PubMed ID: 22166463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term follow-up of Parkinson's disease patients with impulse control disorders.
    Sohtaoğlu M; Demiray DY; Kenangil G; Ozekmekçi S; Erginöz E
    Parkinsonism Relat Disord; 2010 Jun; 16(5):334-7. PubMed ID: 20223696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
    Weintraub D
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S110-3. PubMed ID: 20082968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
    Ceravolo R; Frosini D; Rossi C; Bonuccelli U
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders and depression in Finnish patients with Parkinson's disease.
    Joutsa J; Martikainen K; Vahlberg T; Voon V; Kaasinen V
    Parkinsonism Relat Disord; 2012 Feb; 18(2):155-60. PubMed ID: 21983019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
    Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
    Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
    Voon V; Potenza MN; Thomsen T
    Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas.
    Martinkova J; Trejbalova L; Sasikova M; Benetin J; Valkovic P
    Clin Neuropharmacol; 2011; 34(5):179-81. PubMed ID: 21738024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.
    Limotai N; Oyama G; Go C; Bernal O; Ong T; Moum SJ; Bhidayasiri R; Foote KD; Bowers D; Ward H; Okun MS
    Int J Neurosci; 2012 Mar; 122(3):145-53. PubMed ID: 22023411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
    Voon V; Hassan K; Zurowski M; de Souza M; Thomsen T; Fox S; Lang AE; Miyasaki J
    Neurology; 2006 Oct; 67(7):1254-7. PubMed ID: 16957130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
    Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
    J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.